NFKB1 and Insulin resistance: Inflammation and insulin resistance can trigger metabolic disorders that activate inflammatory transcription factor nuclear factor-κB (NF-κB) and the inflammatory signaling system, as well as elevated cytokine levels, thus accelerating damage to endothelial cell function and formation of atherosclerotic plaques.